115 related articles for article (PubMed ID: 38234048)
1. Application of temperature-dependent and steered molecular dynamics simulation to screen anti-dengue compounds against Marburg virus.
Rabaan AA; Almansour ZH; Al Bshabshe A; Halwani MA; Al-Subaie MF; Al Kaabi NA; Alshamrani SA; Alshehri AA; Nahari MH; Alqahtani AS; Alhajri M; Alissa M
J Biomol Struct Dyn; 2024 Jan; ():1-20. PubMed ID: 38234048
[TBL] [Abstract][Full Text] [Related]
2. Assessing the inhibitory potential of anti-dengue compounds against Japanese encephalitis virus RNA dependent RNA polymerase: an in silico study.
Bajrai LH; Alandijany TA; Alsaady I; El-Daly MM; Tolah AM; Khateb AM; Dubey A; Dwivedi VD; Azhar EI
J Biomol Struct Dyn; 2023 Oct; ():1-17. PubMed ID: 37811742
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of SARS-CoV-2 compounds against Marburg Virus using MD simulation, mm/GBSA, PCA analysis, and free energy landscape.
Kumar S; Dubey R; Mishra R; Gupta S; Dwivedi VD; Ray S; Jha NK; Verma D; Tsai LW; Dubey NK
J Biomol Struct Dyn; 2024 Mar; ():1-20. PubMed ID: 38450706
[TBL] [Abstract][Full Text] [Related]
4. Exploration of phytochemical compounds against Marburg virus using QSAR, molecular dynamics, and free energy landscape.
Rabaan AA; Halwani MA; Garout M; Alotaibi J; AlShehail BM; Alotaibi N; Almuthree SA; Alshehri AA; Alshahrani MA; Othman B; Alqahtani A; Alissa M
Mol Divers; 2023 Nov; ():. PubMed ID: 37925643
[TBL] [Abstract][Full Text] [Related]
5. Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library.
Alsaady IM; Bajrai LH; Alandijany TA; Gattan HS; El-Daly MM; Altwaim SA; Alqawas RT; Dwivedi VD; Azhar EI
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632081
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics.
Tanbin S; Ahmad Fuad FA; Abdul Hamid AA
BioTech (Basel); 2020 Dec; 10(1):. PubMed ID: 35822774
[TBL] [Abstract][Full Text] [Related]
7. Antiviral actions of natural compounds against dengue virus RNA dependent RNA polymerase: insights from molecular dynamics and Gibbs free energy landscape.
Rabaan AA; Al Kaabi NA; Muzaheed ; Alfaresi M; Garout M; Alotaibi N; Alwashmi ASS; Alsayyah A; Alali NA; Sulaiman T; Alotaibi J; Alissa M
J Biomol Struct Dyn; 2024 Mar; ():1-18. PubMed ID: 38441606
[TBL] [Abstract][Full Text] [Related]
8. Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach.
Alhazmi AY; Khan FR; Rehman ZU; Hazazi A; Alotaibi BS; Alharthi NS; Alhuthali HM; Aba Alkhayl FF; Alshehri FF; Alkhoshaiban A; Al-Otaibi F
J Biomol Struct Dyn; 2024 Feb; ():1-18. PubMed ID: 38407246
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Mechanism of Action of Anti-Dengue Compounds as Potential Binders of Zika Virus RNA-Dependent RNA Polymerase.
Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Alsaady IM; Altwaim SA; Dubey A; Dwivedi VD; Azhar EI
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515188
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
[TBL] [Abstract][Full Text] [Related]
11. Exploration of comprehensive marine natural products database against dengue viral non-structural protein 1 using high-throughput computational studies.
Bhat BA; Algaissi A; Khamjan NA; Dar TUH; Dar SA; Varadharajan V; Qasir NA; Lohani M
J Biomol Struct Dyn; 2024 Jan; ():1-10. PubMed ID: 38165485
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
13. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
[TBL] [Abstract][Full Text] [Related]
14. Identification of neo-andrographolide compound targeting NS1 Lys14: an important residue in NS1 activity driving dengue pathogenesis.
Elumalai E; Suresh Kumar M
J Biomol Struct Dyn; 2023 Jul; 41(10):4504-4514. PubMed ID: 35491708
[TBL] [Abstract][Full Text] [Related]
15. Exploration of potent antiviral phytomedicines from Lauraceae family plants against SARS-CoV-2 RNA-dependent RNA polymerase.
Rabaan AA; Halwani MA; Aljeldah M; Al Shammari BR; Garout M; Aldali J; Alawfi A; Alshengeti A; Alsulaiman AM; Alsayyah A
J Biomol Struct Dyn; 2023; 41(24):15085-15105. PubMed ID: 36883874
[TBL] [Abstract][Full Text] [Related]
16. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of
Joshi T; Joshi T; Sharma P; Chandra S; Pande V
J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918
[No Abstract] [Full Text] [Related]
18. Inhibitor screening for volume-sensitive LRRC8A chloride channel.
Liu C; Cui W; Zhu K; Yuan S; Sun L; Liang Y; Lu J; Li D; Deng Z; Duan L; Zhang W; Yu X; Wang D; Zhang H
J Biomol Struct Dyn; 2023 Oct; ():1-9. PubMed ID: 37902556
[TBL] [Abstract][Full Text] [Related]
19. Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations.
Ahamad S; Gupta D; Kumar V
J Biomol Struct Dyn; 2022 Apr; 40(6):2430-2443. PubMed ID: 33140703
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput molecular dynamics screening (HTMDS) approach to the design of novel cyclopeptide inhibitors of ATAD2B based on the non-canonical combinatorial library.
Chen Z; Li Y; Wang X; Qiu X; Wang C; Wang Z; Chen X; Wang J
J Biomol Struct Dyn; 2024 Apr; 42(6):2809-2824. PubMed ID: 37194299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
